Trade Names: | |
Synonyms: | |
Status: | Approved (1998) |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
ATC: | L04AC02 |
UNII: | 9927MT646M |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Interleukin-2 receptor inhibitor | DailyMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Graft vs Host Disease | 3 | D006086 | ClinicalTrials |
Reperfusion Injury | 3 | D015427 | ClinicalTrials |
Emphysema | 3 | D004646 | ClinicalTrials |
Infections | 3 | D007239 | ClinicalTrials |
Diabetes Mellitus, Type 1 | 3 | D003922 | ClinicalTrials |
Glioblastoma | 2 | D005909 | ClinicalTrials |
Granuloma, Lethal Midline | 2 | D006103 | ClinicalTrials |
Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials |
Uveitis | 2 | D014605 | ClinicalTrials |
Hodgkin Disease | 2 | D006689 | ClinicalTrials |
Amyotrophic Lateral Sclerosis | 2 | D000690 | ClinicalTrials |
Glomerulosclerosis, Focal Segmental | 2 | D005923 | ClinicalTrials |
Kidney Diseases | 2 | D007674 | ClinicalTrials |
Kidney Tubular Necrosis, Acute | 1 | D007683 | ClinicalTrials |
DiGeorge Syndrome | 1 | D004062 | ClinicalTrials |
Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Multiple Myeloma | 1 | D009101 | ClinicalTrials |
Uremia | 1 | D014511 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 179045-86-4 |
ChEMBL | CHEMBL1201439 |
FDA SRS | 9927MT646M |
Guide to Pharmacology | 6879 |